Testing effectiveness (Phase 2)Study completedNCT05207995
What this trial is testing
The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells
Who this might be right for
Diabetes Mellitus
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 32